Participants 45 95 3
anemic cancer patients on combination chemotherapy
Participants 109 191 4
Patients with advanced cancer frequently experience clinically significant anemia,
Participants 823 924 4
patients with advanced cancer who were receiving myelosuppressive chemotherapy (excluding cisplatin).
Participants 944 1082 5
153 anemic cancer patients receiving cyclic combination chemotherapy in a prospective multicenter, double-blind, placebo-controlled trial.
